Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olli Ritvos

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Endocrinology|December 19, 2002
Growth differentiation factor-9 stimulates inhibin production and activates Smad2 in cultured rat granulosa cellsJae-Sook Roh, Jonas Bondestam, Sabine Mazerbourg, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 23, 2013
Exercise restores decreased physical activity levels and increases markers of autophagy and oxidative capacity in myostatin/activin-blocked mdx miceJuha J Hulmi, Bernardo M Oliveira, Mika Silvennoinen, et al.
Frontiers in Bioengineering and Biotechnology|November 12, 2021
Adapting the Scar-in-a-Jar to Skin Fibrosis and Screening Traditional and Contemporary Anti-Fibrotic TherapiesJoão Q Coentro, Ulrike May, Stuart Prince, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 13, 2019
Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockadeJuulia H Lautaoja, Maciej Lalowski, Tuuli A Nissinen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 9, 2021
Muscle follistatin gene delivery increases muscle protein synthesis independent of periodical physical inactivity and fastingTuuli A Nissinen, Jaakko Hentilä, Vasco Fachada, et al.
BMC Musculoskeletal Disorders|January 21, 2017
Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophyTero Puolakkainen, Hongqian Ma, Heikki Kainulainen, et al.
Frontiers in Physiology|February 5, 2019
Activin Receptor Ligand Blocking and Cancer Have Distinct Effects on Protein and Redox Homeostasis in Skeletal Muscle and LiverJaakko Hentilä, Tuuli A Nissinen, Ayhan Korkmaz, et al.
Endocrine-Related Cancer|January 12, 2023
Inhibition of activin signalling reduces the growth of LβT2 gonadotroph pituitary tumours in mouseAudrey Ziverec, Marie Chanal, Perrine Raymond, et al.
Pregnancy Hypertension|June 11, 2021
Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk womenElina Keikkala, Janina Forstén, Olli Ritvos, et al.
Molecular Endocrinology (Baltimore, Md.)|December 20, 2003
Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5Sabine Mazerbourg, Cynthia Klein, Jaesook Roh, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Endocrinology|December 19, 2002
Growth differentiation factor-9 stimulates inhibin production and activates Smad2 in cultured rat granulosa cellsJae-Sook Roh, Jonas Bondestam, Sabine Mazerbourg, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 23, 2013
Exercise restores decreased physical activity levels and increases markers of autophagy and oxidative capacity in myostatin/activin-blocked mdx miceJuha J Hulmi, Bernardo M Oliveira, Mika Silvennoinen, et al.
Frontiers in Bioengineering and Biotechnology|November 12, 2021
Adapting the Scar-in-a-Jar to Skin Fibrosis and Screening Traditional and Contemporary Anti-Fibrotic TherapiesJoão Q Coentro, Ulrike May, Stuart Prince, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 13, 2019
Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockadeJuulia H Lautaoja, Maciej Lalowski, Tuuli A Nissinen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 9, 2021
Muscle follistatin gene delivery increases muscle protein synthesis independent of periodical physical inactivity and fastingTuuli A Nissinen, Jaakko Hentilä, Vasco Fachada, et al.
BMC Musculoskeletal Disorders|January 21, 2017
Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophyTero Puolakkainen, Hongqian Ma, Heikki Kainulainen, et al.
Frontiers in Physiology|February 5, 2019
Activin Receptor Ligand Blocking and Cancer Have Distinct Effects on Protein and Redox Homeostasis in Skeletal Muscle and LiverJaakko Hentilä, Tuuli A Nissinen, Ayhan Korkmaz, et al.
Endocrine-Related Cancer|January 12, 2023
Inhibition of activin signalling reduces the growth of LβT2 gonadotroph pituitary tumours in mouseAudrey Ziverec, Marie Chanal, Perrine Raymond, et al.
Pregnancy Hypertension|June 11, 2021
Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk womenElina Keikkala, Janina Forstén, Olli Ritvos, et al.
Molecular Endocrinology (Baltimore, Md.)|December 20, 2003
Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5Sabine Mazerbourg, Cynthia Klein, Jaesook Roh, et al.
Pageof 9